Tokyo Tape
Sign in
← I'rom Group

Quarterly report · Q1

2372.TEDINET S100OU1N
Period2022-04-01 → 2022-06-30
Filed2022-08-05
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 34
MetricValuePeriodScopeSource row
Revenue¥4.8bn2022-04-01 → 2022-06-30Cons.Net sales
Revenue¥15.7bn2021-04-01 → 2022-03-31Cons.Net sales (5-year summary)
Revenue¥3.4bn2021-04-01 → 2021-06-30Cons.Net sales
Operating income¥1.4bn2022-04-01 → 2022-06-30Cons.Operating income
Operating income¥354m2021-04-01 → 2021-06-30Cons.Operating income
Ordinary income¥1.4bn2022-04-01 → 2022-06-30Cons.Ordinary income
Ordinary income¥2.6bn2021-04-01 → 2022-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥439m2021-04-01 → 2021-06-30Cons.Ordinary income
Profit before tax¥1.5bn2022-04-01 → 2022-06-30Cons.Income before income taxes
Profit before tax¥440m2021-04-01 → 2021-06-30Cons.Income before income taxes
Net income (owners)¥1.1bn2022-04-01 → 2022-06-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥2.0bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥258m2021-04-01 → 2021-06-30Cons.Profit loss attributable to owners of parent
Net income¥1.1bn2022-04-01 → 2022-06-30Cons.Profit loss
Net income¥255m2021-04-01 → 2021-06-30Cons.Profit loss
Total assets¥28.2bnat 2022-06-30Cons.Assets
Total assets¥26.6bnat 2022-03-31Cons.Assets
Total assets¥21.8bnat 2021-06-30Cons.Total assets (5-year summary)
Total liabilities¥17.2bnat 2022-06-30Cons.Liabilities
Total liabilities¥16.4bnat 2022-03-31Cons.Liabilities
Net assets / equity¥11.0bnat 2022-06-30Cons.Net assets
Net assets / equity¥10.2bnat 2022-03-31Cons.Net assets
Net assets / equity¥8.6bnat 2021-06-30Cons.Net assets (5-year summary)
Cash and deposits¥5.9bnat 2022-06-30Cons.Cash and deposits
Cash and deposits¥6.4bnat 2022-03-31Cons.Cash and deposits
EPS (basic)¥88.372022-04-01 → 2022-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥162.52021-04-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥21.482021-04-01 → 2021-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥88.222022-04-01 → 2022-06-30Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥162.172021-04-01 → 2022-03-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥21.422021-04-01 → 2021-06-30Cons.Diluted earnings per share (5-year summary)
Equity ratio38.9%at 2022-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio38.1%at 2022-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio39.3%at 2021-06-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 62
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-04-01 → 2022-06-30¥23m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-04-01 → 2022-06-30¥3m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2022-04-01 → 2022-06-30¥19m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-04-01 → 2022-06-30−¥45m
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-06-30−¥357m
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-06-30−¥357m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-06-30−¥364m
jpcrp040300-q1r_E05352-000Advanced Medicinal Treatmentreportable segmentrevenue2022-04-01 → 2022-06-30¥385m
jpcrp040300-q1r_E05352-000Advanced Medicinal Treatmentreportable segmentrevenue external2022-04-01 → 2022-06-30¥374m
jpcrp040300-q1r_E05352-000Advanced Medicinal Treatmentreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥10m
jpcrp040300-q1r_E05352-000Advanced Medicinal Treatmentreportable segmentsegment profit2022-04-01 → 2022-06-30¥42m
jpcrp040300-q1r_E05352-000CROreportable segmentrevenue2022-04-01 → 2022-06-30¥1.3bn
jpcrp040300-q1r_E05352-000CROreportable segmentrevenue external2022-04-01 → 2022-06-30¥1.3bn
jpcrp040300-q1r_E05352-000CROreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥75m
jpcrp040300-q1r_E05352-000CROreportable segmentsegment profit2022-04-01 → 2022-06-30¥61m
jpcrp040300-q1r_E05352-000Medical Supportreportable segmentrevenue2022-04-01 → 2022-06-30¥468m
jpcrp040300-q1r_E05352-000Medical Supportreportable segmentrevenue external2022-04-01 → 2022-06-30¥241m
jpcrp040300-q1r_E05352-000Medical Supportreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥226m
jpcrp040300-q1r_E05352-000Medical Supportreportable segmentsegment profit2022-04-01 → 2022-06-30¥36m
jpcrp040300-q1r_E05352-000SMOreportable segmentrevenue2022-04-01 → 2022-06-30¥2.9bn
jpcrp040300-q1r_E05352-000SMOreportable segmentrevenue external2022-04-01 → 2022-06-30¥2.9bn
jpcrp040300-q1r_E05352-000SMOreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥24m
jpcrp040300-q1r_E05352-000SMOreportable segmentsegment profit2022-04-01 → 2022-06-30¥1.7bn
—segment totalrevenue2022-04-01 → 2022-06-30¥5.1bn
—segment totalrevenue external2022-04-01 → 2022-06-30¥4.8bn
—segment totalrevenue intersegment2022-04-01 → 2022-06-30¥337m
—segment totalsegment profit2022-04-01 → 2022-06-30¥1.9bn
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-06-30¥5.1bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-06-30¥4.8bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-06-30¥357m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-06-30¥1.8bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2021-04-01 → 2021-06-30¥6m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2021-04-01 → 2021-06-30¥4m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2021-04-01 → 2021-06-30¥2m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2021-04-01 → 2021-06-30−¥60m
Reconciling Itemsreconcilingrevenue2021-04-01 → 2021-06-30−¥217m
Reconciling Itemsreconcilingrevenue intersegment2021-04-01 → 2021-06-30−¥217m
Reconciling Itemsreconcilingsegment profit2021-04-01 → 2021-06-30−¥303m
jpcrp040300-q1r_E05352-000Advanced Medicinal Treatmentreportable segmentrevenue2021-04-01 → 2021-06-30¥166m
jpcrp040300-q1r_E05352-000Advanced Medicinal Treatmentreportable segmentrevenue external2021-04-01 → 2021-06-30¥164m
jpcrp040300-q1r_E05352-000Advanced Medicinal Treatmentreportable segmentrevenue intersegment2021-04-01 → 2021-06-30¥1m
jpcrp040300-q1r_E05352-000Advanced Medicinal Treatmentreportable segmentsegment profit2021-04-01 → 2021-06-30−¥162m
jpcrp040300-q1r_E05352-000CROreportable segmentrevenue2021-04-01 → 2021-06-30¥1.1bn
jpcrp040300-q1r_E05352-000CROreportable segmentrevenue external2021-04-01 → 2021-06-30¥1.1bn
jpcrp040300-q1r_E05352-000CROreportable segmentrevenue intersegment2021-04-01 → 2021-06-30¥16m
jpcrp040300-q1r_E05352-000CROreportable segmentsegment profit2021-04-01 → 2021-06-30¥71m
jpcrp040300-q1r_E05352-000Medical Supportreportable segmentrevenue2021-04-01 → 2021-06-30¥390m
jpcrp040300-q1r_E05352-000Medical Supportreportable segmentrevenue external2021-04-01 → 2021-06-30¥228m
jpcrp040300-q1r_E05352-000Medical Supportreportable segmentrevenue intersegment2021-04-01 → 2021-06-30¥161m
jpcrp040300-q1r_E05352-000Medical Supportreportable segmentsegment profit2021-04-01 → 2021-06-30¥21m
jpcrp040300-q1r_E05352-000SMOreportable segmentrevenue2021-04-01 → 2021-06-30¥1.9bn
jpcrp040300-q1r_E05352-000SMOreportable segmentrevenue external2021-04-01 → 2021-06-30¥1.9bn
jpcrp040300-q1r_E05352-000SMOreportable segmentrevenue intersegment2021-04-01 → 2021-06-30¥35m
jpcrp040300-q1r_E05352-000SMOreportable segmentsegment profit2021-04-01 → 2021-06-30¥787m
—segment totalrevenue2021-04-01 → 2021-06-30¥3.6bn
—segment totalrevenue external2021-04-01 → 2021-06-30¥3.4bn
—segment totalrevenue intersegment2021-04-01 → 2021-06-30¥215m
—segment totalsegment profit2021-04-01 → 2021-06-30¥717m
Total Of Reportable Segments And Otherssegment totalrevenue2021-04-01 → 2021-06-30¥3.6bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-04-01 → 2021-06-30¥3.4bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2021-04-01 → 2021-06-30¥217m
Total Of Reportable Segments And Otherssegment totalsegment profit2021-04-01 → 2021-06-30¥657m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 404
ItemContextValueUnit
Revenues from external customersPrior1YTDDuration_ReportableSegmentsMember3383000000JPY
Revenues from external customersPrior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember4000000JPY
Revenues from external customersPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember3388000000JPY
Revenues from external customersPrior1YTDDuration_ReconcilingItemsMember－JPY
Revenues from external customersPrior1YTDDuration3388000000JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q1r_E05352-000SMOReportableSegmentsMember35000000JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q1r_E05352-000CROReportableSegmentMember16000000JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q1r_E05352-000AdvancedMedicinalTreatmentReportableSegmentMember1000000JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q1r_E05352-000MedicalSupportReportableSegmentsMember161000000JPY
Transactions with other segmentsPrior1YTDDuration_ReportableSegmentsMember215000000JPY
Transactions with other segmentsPrior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember2000000JPY
Transactions with other segmentsPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember217000000JPY
Transactions with other segmentsPrior1YTDDuration_ReconcilingItemsMember-217000000JPY
Transactions with other segmentsPrior1YTDDuration－JPY
Net salesPrior1YTDDuration_jpcrp040300-q1r_E05352-000SMOReportableSegmentsMember1905000000JPY
Net salesPrior1YTDDuration_jpcrp040300-q1r_E05352-000CROReportableSegmentMember1136000000JPY
Net salesPrior1YTDDuration_jpcrp040300-q1r_E05352-000AdvancedMedicinalTreatmentReportableSegmentMember166000000JPY
Net salesPrior1YTDDuration_jpcrp040300-q1r_E05352-000MedicalSupportReportableSegmentsMember390000000JPY
Net salesPrior1YTDDuration_ReportableSegmentsMember3598000000JPY
Net salesPrior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember6000000JPY
Net salesPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember3605000000JPY
Net salesPrior1YTDDuration_ReconcilingItemsMember-217000000JPY
Net salesPrior1YTDDuration3388000000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q1r_E05352-000SMOReportableSegmentsMember787000000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q1r_E05352-000CROReportableSegmentMember71000000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q1r_E05352-000AdvancedMedicinalTreatmentReportableSegmentMember-162000000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q1r_E05352-000MedicalSupportReportableSegmentsMember21000000JPY
Operating incomePrior1YTDDuration_ReportableSegmentsMember717000000JPY
Operating incomePrior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember-60000000JPY
Operating incomePrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember657000000JPY
Operating incomePrior1YTDDuration_ReconcilingItemsMember-303000000JPY
Operating incomePrior1YTDDuration354000000JPY
Revenues from external customersCurrentYTDDuration_jpcrp040300-q1r_E05352-000SMOReportableSegmentsMember2907000000JPY
Revenues from external customersCurrentYTDDuration_jpcrp040300-q1r_E05352-000CROReportableSegmentMember1265000000JPY
Revenues from external customersCurrentYTDDuration_jpcrp040300-q1r_E05352-000AdvancedMedicinalTreatmentReportableSegmentMember374000000JPY
Revenues from external customersCurrentYTDDuration_jpcrp040300-q1r_E05352-000MedicalSupportReportableSegmentsMember241000000JPY
Revenues from external customersCurrentYTDDuration_ReportableSegmentsMember4788000000JPY
Revenues from external customersCurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember3000000JPY
Revenues from external customersCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember4792000000JPY
Revenues from external customersCurrentYTDDuration_ReconcilingItemsMember－JPY
Revenues from external customersCurrentYTDDuration4792000000JPY
Transactions with other segmentsCurrentYTDDuration_jpcrp040300-q1r_E05352-000SMOReportableSegmentsMember24000000JPY
Transactions with other segmentsCurrentYTDDuration_jpcrp040300-q1r_E05352-000CROReportableSegmentMember75000000JPY
Transactions with other segmentsCurrentYTDDuration_jpcrp040300-q1r_E05352-000AdvancedMedicinalTreatmentReportableSegmentMember10000000JPY
Transactions with other segmentsCurrentYTDDuration_jpcrp040300-q1r_E05352-000MedicalSupportReportableSegmentsMember226000000JPY
Transactions with other segmentsCurrentYTDDuration_ReportableSegmentsMember337000000JPY
Transactions with other segmentsCurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember19000000JPY
Transactions with other segmentsCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember357000000JPY
Transactions with other segmentsCurrentYTDDuration_ReconcilingItemsMember-357000000JPY
Transactions with other segmentsCurrentYTDDuration－JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-03-31pass
balance sheet identityconsolidated 2022-06-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsconsolidated 2022-06-30pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-06-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-06-30pass
statement vs summary · revenueconsolidated 2021-04-01/2021-06-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-06-30pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-06-30pass